Ulta Lab Tests LogoContact Us

Category: Diabetes

September 19, 2026

FIB-4 Score Explained: Calculation and Age Cutoffs

Learn How to Calculate and Understand Your FIB-4 Score for Better Liver Health

Calculate the score correctly, apply age-appropriate thresholds, and understand when another assessment is needed. A FIB-4 score estimates the probability of advanced liver fibrosis using age, AST, ALT, and platelet count. It is a risk-stratification […]

Read More
September 18, 2026

MASLD Blood Tests: What Fatty Liver Testing Can Reveal

Understand MASLD and MASH, what initial blood tests can reveal, and when imaging or a separate fibrosis assessment is needed.

Understand fatty liver terminology, the purpose of initial blood tests, and when imaging or further assessment may be needed. MASLD blood tests help evaluate liver injury, metabolic risk, and possible alternative causes, but they cannot […]

Read More
September 10, 2026

Prediabetes and Type 2 Diabetes: Why A1C, Fasting Glucose, OGTT, Kidney, and Lipid Testing Must Be Read Together

How to read glucose, kidney, lipid, and liver results together and understand when additional testing or follow-up may be needed.

Glucose results tell you about blood sugar. Kidney, lipid, and liver results answer additional questions about your health. A person can have an improving A1C while urine albumin remains elevated, cholesterol-related risk persists, or liver […]

Read More
September 3, 2026

Can Fatigue Be an Early Sign of Diabetes? Symptoms, Blood Tests, and Other Causes

When unusual tiredness may point to high blood sugar, which tests can clarify the cause, and when another explanation is more likely.

Fatigue can occur with diabetes, but tiredness by itself cannot tell you whether your blood sugar is high. The most useful clues are the pattern of fatigue, the symptoms that appear with it, your risk […]

Read More
September 2, 2026

Metabolic Syndrome Blood Tests: The 5 Criteria and What Results Mean

How waist circumference, blood pressure, fasting glucose, triglycerides, and HDL identify a connected cardiometabolic risk pattern.

Direct Answer Metabolic syndrome is a cluster of cardiometabolic risk factors, not a single blood-test result. A healthcare professional commonly identifies it when at least three of five findings are present: increased waist circumference, elevated […]

Read More
September 1, 2026

HOMA2-IR, HOMA2-%B, and HOMA2-%S Explained

What the fasting HOMA2 model can—and cannot—tell you about insulin sensitivity, insulin resistance, and beta-cell activity.

HOMA2-IR, HOMA2-%B & HOMA2-%S Explained Direct answer: HOMA2 is a nonlinear computer model, not a stand-alone blood test. From compatible fasting glucose with insulin or C-peptide, it estimates insulin sensitivity (HOMA2-%S), the reciprocal insulin-resistance index […]

Read More
August 27, 2026

What can I do to reduce the risk of type 2 diabetes?

Unlocking Prevention: Lab Testing as Your Guide to Reduce the Risk of Type 2 Diabetes

Type 2 diabetes cannot always be prevented, but many people can substantially lower or delay their risk. The most effective approach is to identify prediabetes early, build sustainable eating and activity habits, improve sleep, avoid […]

Read More
August 27, 2026

Is Falling Asleep After Eating a Sign of Diabetes?

What post-meal sleepiness can - and cannot - tell you about blood sugar, diabetes risk, and other common causes of fatigue.

Short answer: Falling asleep after eating is not, by itself, a reliable sign of diabetes. Post-meal sleepiness, also called postprandial somnolence, can occur because of a normal early-afternoon dip in alertness, insufficient sleep, a large […]

Read More
August 27, 2026

High A1C Levels Without Diabetes: Is It Possible

A high A1C can reflect true dysglycemia, red-blood-cell changes, or an assay interference. The right next step is confirmation—not assuming that you do or do not have diabetes.

It is possible to have a high A1C without an established diabetes diagnosis. An A1C of 5.7% to 6.4% is in the prediabetes range. An A1C of 6.5% or higher meets a diabetes diagnostic threshold, […]

Read More
August 27, 2026

Insulin Resistance Diet: Foods, Meals, and Lab Tests

A flexible, evidence-based approach to foods, meal planning, carbohydrate quality, and appropriate laboratory follow-up.

An insulin resistance diet is not one prescribed menu. It is a flexible eating pattern that emphasizes nonstarchy vegetables, fiber-rich carbohydrate foods, protein, and unsaturated fats while limiting sugary drinks, refined grains, and heavily processed […]

Read More
August 27, 2026

Insulin Resistance as an Early-Warning System: Lab Patterns That Reveal Metabolic Strain

A focused guide to what A1C, fasting glucose, fasting insulin, triglycerides, HDL, ApoB, CMP, kidney, and selected inflammation markers can—and cannot—show before type 2 diabetes becomes obvious.

Insulin resistance can develop quietly. Early in the process, the pancreas may release more insulin to keep glucose in the usual range. A normal fasting glucose therefore does not always mean the glucose-insulin system is […]

Read More
August 27, 2026

Insulin Resistance and Type 2 Diabetes: Risk, Testing, and Prevention

How insulin resistance can progress to prediabetes and type 2 diabetes, which standard tests identify that progression, and what prevention can realistically accomplish.

Direct answer: Insulin resistance occurs when muscle, fat, and liver cells respond less effectively to insulin. The pancreas may compensate by releasing more insulin, allowing glucose to remain within the usual range for a time. […]

Read More
August 27, 2026

1,5-Anhydroglucitol (1,5-AG): When A1C May Miss Recent Glucose Spikes

An evidence-based guide to the narrow role of 1,5-AG as an adjunct—not a replacement—for A1C, plasma glucose, home monitoring, or continuous glucose data.

A1C and 1,5-anhydroglucitol do not compete for the same job. A1C is an established test for diabetes screening, diagnosis, and longer-term monitoring. 1,5-anhydroglucitol (1,5-AG) is a narrower adjunctive marker that may fall when glucose has […]

Read More
August 25, 2026

PMOS (Formerly PCOS) and Diabetes Risk: Why a Normal A1C May Not Tell the Whole Story

Learn why PMOS can increase impaired glucose tolerance and type 2 diabetes risk—and why OGTT, A1C, fasting glucose, lipids, and metabolic trends should be read together.

Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly called Polycystic Ovary Syndrome (PCOS), is both a reproductive and metabolic condition. The diabetes connection is important because glucose dysregulation can develop even when fasting glucose, A1C, or body […]

Read More
August 11, 2026

Diabetes and Prediabetes Blood Tests: A1C, Glucose, Insulin, and C-Peptide

Compare diabetes blood tests—including A1C, fasting glucose, OGTT, insulin, and C-peptide—for screening, diagnostic support, and ongoing monitoring.

Diabetes blood tests are not interchangeable. In nonpregnant adults, A1C, fasting plasma glucose, and the two-hour plasma glucose value from a 75-gram oral glucose tolerance test can be used for screening and diagnostic support. A […]

Read More
August 11, 2026

Metabolic Health Blood Tests: Weight Loss, Insulin Resistance, and GLP-1 Monitoring

What blood tests are used for metabolic health, weight loss, and GLP-1 monitoring? Metabolic health blood tests can help evaluate glucose regulation, cardiovascular risk, liver and kidney function, thyroid function, blood-cell patterns, and selected nutrient […]

Read More
August 11, 2026

Brain and Neurological Blood Tests: Memory Loss, Migraine, Neuropathy, and Alzheimer’s Biomarkers

Neurological Blood Tests: The Direct Answer Neurological blood tests can help identify treatable or clinically relevant contributors to memory change, numbness, weakness, headache, balance problems, and other neurological symptoms. Common questions involve blood-cell patterns, glucose […]

Read More
August 11, 2026

Pregnancy Blood Tests and Prenatal Screening: hCG, Genetic Screening, and Tests by Trimester

A trimester-by-trimester guide to hCG, blood type and Rh, CBC, urine and infection screening, gestational diabetes, thyroid, iron, and prenatal genetic testing.

Pregnancy blood tests and prenatal urine tests are used for several different purposes. Early testing commonly evaluates pregnancy hormone status when needed, blood counts, blood type and Rh factor, unexpected red-cell antibodies, urine bacteria, immunity […]

Read More
July 29, 2026

Adrenal Insufficiency: When Fatigue, Low Blood Pressure, and Electrolyte Changes May Signal Cortisol Deficiency

How cortisol, ACTH, sodium, potassium, renin, and aldosterone testing can clarify persistent fatigue, dizziness, and low blood pressure

A pattern-based guide to separating primary adrenal failure from pituitary, hypothalamic, and medication-related cortisol deficiency—and to recognizing when outpatient testing is no longer appropriate. Addison’s disease is not diagnosed by fatigue, salt craving, low sodium, […]

Read More
July 23, 2026

How Often Should People With High Blood Pressure Get Heart Health Screenings?

n evidence-based guide to hypertension blood tests, cardiovascular screening frequency, kidney monitoring, and advanced heart-risk biomarkers.

High blood pressure, also called hypertension, increases the long-term risk of heart attack, stroke, heart failure, atrial fibrillation, kidney disease, and other complications. Because hypertension can affect several body systems without causing obvious symptoms, ongoing […]

Read More
July 18, 2026

Obstructive Sleep Apnea: When Poor Sleep Becomes a Whole-Body Health Risk

How nighttime airway blockages can affect oxygen, energy, blood pressure, blood sugar, heart health, hormones, and performance—and where lab testing adds context.

Obstructive sleep apnea, commonly called OSA, is a sleep-related breathing disorder in which the upper airway repeatedly narrows or closes during sleep. Each event may reduce airflow, lower blood oxygen, interrupt normal sleep, and activate […]

Read More
July 15, 2026

Rapid Weight Loss, GLP-1 Medications, and “Toxin Release”: What Patients Should Know

What rapid fat loss may—and may not—release, how GLP-1 side effects can affect hydration and nutrition, and which lab tests may support informed monitoring.

Rapid weight loss with medications such as semaglutide and tirzepatide can lead to meaningful changes in body weight, appetite, blood sugar, and cardiometabolic health. Semaglutide is a glucagon-like peptide-1 receptor agonist, commonly called a GLP-1 […]

Read More
July 14, 2026

GLP-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters

A patient-friendly guide to semaglutide side effects, warning signs, and the blood tests that may help monitor glucose, kidney, liver, pancreatic, and nutritional health.

GLP-1 receptor agonists such as semaglutide can help manage blood glucose, body weight, and certain cardiometabolic risks when prescribed for an appropriate patient. Like all prescription medicines, however, they can cause side effects. Most are […]

Read More
July 8, 2026

Endocrine Disorders: Causes, Symptoms, Lab Tests, and Management

Understand how thyroid, adrenal, pituitary, pancreatic, parathyroid, and reproductive hormone disorders may affect your health—and which lab tests provide useful information.

Endocrine disorders are conditions that interfere with the production, release, transport, or action of hormones. Because hormones help regulate metabolism, blood sugar, growth, reproduction, stress responses, calcium balance, energy, and mood, an endocrine problem can […]

Read More
July 8, 2026

Chronic Disease Management: How Lab Testing Supports Better Health Decisions

A patient-friendly guide to choosing, tracking, and understanding laboratory tests used to support long-term health monitoring.

Managing a chronic condition often involves much more than responding to symptoms. It may require regular medical visits, medication review, lifestyle support, home measurements, and laboratory testing that shows how the body is functioning over […]

Read More
Copyright © 2013-2026 Ulta Lab Tests, LLC All Rights Reserved.